Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Amortizatization of Intangibles: 2013-2025

Historic Amortizatization of Intangibles for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Sep 2025 value amounting to $6.3 million.

  • Amphastar Pharmaceuticals' Amortizatization of Intangibles rose 1.46% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year increase of 0.97%. This contributed to the annual value of $24.7 million for FY2024, which is 92.66% up from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Amortizatization of Intangibles of $6.3 million as of Q3 2025, which was down 0.00% from $6.3 million recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Amortizatization of Intangibles registered a high of $6.3 million during Q2 2025, and its lowest value of $782,000 during Q3 2021.
  • Its 3-year average for Amortizatization of Intangibles is $5.1 million, with a median of $6.2 million in 2023.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Amortizatization of Intangibles dropped by 21.25% in 2021 and then skyrocketed by 585.03% in 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Amortizatization of Intangibles (MRQ) stood at $795,000 in 2021, then grew by 13.46% to $902,000 in 2022, then soared by 585.03% to $6.2 million in 2023, then fell by 0.00% to $6.2 million in 2024, then grew by 1.46% to $6.3 million in 2025.
  • Its last three reported values are $6.3 million in Q3 2025, $6.3 million for Q2 2025, and $6.2 million during Q1 2025.